Event Details
The Company will hold its Q1 FY27 earnings conference call (post-earnings/quarterly call) on Monday, August 03, 2026, at 11:30 a.m. (IST).
The purpose of the call is to discuss the financial results of the Company for the first quarter and three months ended June 30, 2026.
Management Participants
The management team represented on the call will be:
- Mr. Nirav Mehta – Managing Director & CEO
- Mr. Ankur Mehta - Joint Managing Director
- Mr. Bhavin Bhagat - Chief Financial Officer
Call Access Details
Diamond Pass Registration Link: https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=0782677&linkSecurityString=6ad28d1a1
Universal Dial-in Numbers:
- India: +91 22 6280 1222 / +91 22 7115 8123
International Toll-Free Numbers:
- Argentina: 0080014243444
- Australia: 0080014243444
- Belgium: 0080014243444
- Canada: 01180014243444
- China: 4008428405
- France: 0800914745
- Germany: 0080014243444
- Hong Kong: 800964448
- Italy: 0080014243444
- Japan: 00531161110
- Netherlands: 08000229808
- Poland: 008001124248
- Singapore: 8001012045
- South Korea: 00180014243444
- Sweden: 0080014243444
- Thailand: 00180014243444
- UK: 08081011573
- USA: 18667462133
Event Organizer and Contact Information
The conference call is being held by 360 ONE Capital Market Research.
For further information, contact:
- Mr. Rohit Bhat / Mr. Maulik Varia
- 360 ONE Capital Market Research
Additional Information
This intimation is also available on the company's website at www.coronaremedies.com.
The document was digitally signed by Chetna Dharajiya, Company Secretary and Compliance Officer, on July 22, 2026, at 13:39:59 IST.